Why is there no liver dialysis (Liver Replacement Therapy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There is no liver dialysis equivalent to kidney dialysis because the liver performs numerous complex functions that cannot be easily replicated by an external machine. The liver has over 500 different functions, including protein synthesis, detoxification, bile production, metabolism of carbohydrates, fats, and proteins, and storage of vitamins and minerals [ 1 ]. These diverse biochemical processes involve intricate cellular mechanisms that current technology cannot fully replicate outside the body.

Current Management of Liver Failure

Instead of dialysis, liver failure is managed through supportive care to maintain function until the liver regenerates (in acute failure) or through liver transplantation for end-stage disease [ 1 ]. Some temporary liver support systems like MARS (Molecular Adsorbent Recirculating System) and Prometheus can provide limited detoxification but cannot replace the liver's synthetic and metabolic functions [ 1 ]. These devices serve as bridges to transplantation or recovery rather than true replacements for liver function.

Importance of Liver Transplantation

Liver transplantation (LT) is an established life-saving procedure, and the field of LT has changed in the past 10 years with the expansion of indications, transplantation of patients with acute-on-chronic liver failure, and evolution of transplant oncology [ 1 ]. The purpose of the EASL guidelines is to focus on developments since the previous EASL guidelines published in 2016, highlighting the importance of LT in the management of liver failure [ 1 ].

Future Directions

The development of hepatic regenerative therapies and artificial/bioartificial liver support devices that will serve as a bridge to LT or even as destination therapy for patients with liver failure is of critical importance [ 1 ]. Advanced care planning in patients listed for LT occurs infrequently, and engaging palliative care in all listed patients who develop ACLF is necessary [ 1 ].

Key Points

  • The liver's complex functions cannot be replicated by an external machine.
  • Liver failure is managed through supportive care or liver transplantation.
  • Temporary liver support systems can provide limited detoxification but are not a replacement for liver function.
  • Liver transplantation is a life-saving procedure with expanding indications.
  • Development of new therapies and devices is crucial for the management of liver failure.

From the Research

Liver Dialysis

  • There is no established liver dialysis treatment for acute liver failure, as the current systems, such as MARS and Prometheus, have failed to show survival benefits in patients with acute-on-chronic liver failure 2.
  • The development of newer devices with improved functionality is underway, but larger randomized trials are needed to prove their effectiveness in enabling restoration of the complex dysregulated immune system and impacting organ failure and mortality in these patients 2.

Acute Liver Failure Treatment

  • The treatment for acute liver failure is mainly focused on preventing complications and treating associated organ dysfunctions, with liver transplantation being the only life-saving measure in progressive cases 3, 4.
  • N-acetylcysteine (NAC) has been used in the treatment of non-acetaminophen-induced acute liver failure, but the evidence is inconclusive, and its use is not supported by robust clinical evidence 5, 4, 6.
  • The use of extracorporeal artificial liver devices in clinical practice is yet to be supported by evidence, and their effectiveness in treating acute liver failure is still being researched 4.

Challenges in Liver Dialysis

  • The development of an effective liver dialysis system is challenging due to the complexity of liver functions and the need for a system that can provide temporary functional support until the donor liver becomes available or the failing liver regenerates 2.
  • The removal of hepatotoxic metabolites and inhibitors of hepatic regeneration by liver dialysis is crucial in providing a suitable microenvironment and supporting the failing liver, but the current systems have failed to achieve this goal 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Acute Liver Failure].

Deutsche medizinische Wochenschrift (1946), 2025

Research

Acute liver failure.

Current opinion in critical care, 2022

Research

Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 2017

Research

N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure.

The Cochrane database of systematic reviews, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.